MW 390.5 Da, Purity >99%. Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.
AI838772, AW493413, CD309, CD309 antigen, EC 2.7.10.1, FLJ11090, FLK-1, FLK1, mouse, homolog of, Fetal liver kinase 1, KRD1, Kdr, Kinase insert domain receptor, Kinase insert domain receptor (a type III receptor tyrosine kinase), Ly73, MGC104252, MGC112732, Protein-tyrosine kinase receptor flk-1, RP24-311F12.2, SCAN1, TYDP, TYDP1_HUMAN, Tyr-DNA phosphodiesterase 1, Tyrosine kinase growth factor receptor, Tyrosyl-DNA phosphodiesterase 1, VEGFR, VEGFR-2, VGFR2_HUMAN, Vascular endothelial growth factor receptor 2, soluble VEGFR2
MW 390.5 Da, Purity >99%. Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.
Soluble in ethanol to 100 mM.
Soluble in DMSO to 100 mM.
Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.
It is important to note that this product has been reported to be unstable under a variety of conditions. In addition to being unstable to light and air after extended periods of time, this product is extremely unstable in polar solvents such as DMSO. Within 1 hour a DMSO solution showed signs of decomposition. We therefore recommend this material is only stored as the solid form at -20°C (or below), with the exclusion of light and air, and any solutions are made up fresh and used immediately
VEGF Receptor 2 also known as KDR or FLK-1 is a receptor tyrosine kinase with a mass of approximately 200 kDa. This receptor is mainly expressed on endothelial cells and is found in multiple body tissues where angiogenesis occurs such as the lungs and kidneys. VEGF Receptor 2 is responsible for binding to vascular endothelial growth factor (VEGF) which initiates a signaling cascade that promotes cell survival migration and new blood vessel formation.
VEGF Receptor 2 plays an important role in angiogenesis and is essential for vascular development during both physiological and pathological processes. Through interactions with VEGF-A VEGF Receptor 2 forms a signaling complex that activates downstream pathways involved in cellular proliferation and differentiation. This receptor ensures a supply of nutrients and oxygen by facilitating the development of blood vessels in response to hypoxic conditions.
The intracellular signaling initiated by VEGF Receptor 2 involves pathways like the PI3K/Akt pathway and the MAPK/ERK pathway. These pathways are critical for mediating cell survival growth and division. VEGF Receptor 2 is also closely related to VEGF Receptor 1 another member of the same receptor family which can modulate the receptor's activity by acting as a decoy receptor therefore affecting angiogenic responses.
VEGF Receptor 2 has a significant role in cancer and age-related macular degeneration. In many tumors elevated VEGF levels lead to increased activity of VEGF Receptor 2 which results in abnormal blood vessel growth and tumor expansion. The receptor is also implicated in pathological angiogenesis associated with age-related macular degeneration as it promotes neovascularization that can lead to vision loss. Targeting VEGF Receptor 2 for therapeutic interventions often involves VEGF inhibitors which reduce its activity and slow disease progression.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab141447, SU 1498, VEGFR2 inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com